The effect of oriental medicine music therapy on hwa-byung patients
- Conditions
- Hwa-byung (anger syndrome)Mental and Behavioural Disorders
- Registration Number
- ISRCTN11939282
- Lead Sponsor
- Korea Health Industry Development Institute (Korea, South)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 48
1. Male or female over 20
2. Diagnosed as hwa-byung using hwa-byung Structured Clinical Interview (SCID) for Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV)
3. Written informed consent form taken
4. Has no problems with communication (reading, writing, listening, speaking, etc.)
1. In need of regular medication or psychotherapy
2. Has a severe neuro- or psychiatric disorder
3. Has a history of major neuro-psychiatric disorder (autism, learning disorder, mental retardation etc.)
3. Had a change in medication of anti-depressant or barbiturate in the past one month
4. Seriously irritable patient
5. Participated in any other clinical trial in the past 1 month from the screening day
6. Had a regular mind-body relaxation training in the past 1 year, music therapy, qigong, yoga, and meditation
7. Cannot understand written informed consent form or follow this study
8. Mental retardation and mental or emotional problems.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method State-Trait Anxiety Inventory (STAI), measured at Visit 2 (Day 1, their first treatment session), Visit 9 (Day 25, their last treatment session), and Visit 10 (Day 53, the follow-up)
- Secondary Outcome Measures
Name Time Method 1. Hwa-byung scale<br>2. The Center for Epidemiologic Studies Depression Scale (CES-D)<br>3. State-Trait Anger Expression Inventory (STAXI)<br>4. Hwa-byung primary symptoms Visual Analogue Scale (VAS)<br>5. World Health Organization Quality of Life (WHOQOL-BREF)<br>6. Salivary cortisol<br>Measured at Visit 2 (Day 1, their first treatment session), Visit 9 (Day 25, their last treatment session), and Visit 10 (Day 53, the follow-up).